Stockreport

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer [Yahoo! Finance]

BriaCell Therapeutics Corp. - Common Shares  (BCTX) 
PDF The novel mechanisms of action may lead to strong anti-cancer activity in breast and prostate cancer patients “Our data demonstrates enhancement of immune responses a [Read more]